Cargando…
USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis
BACKGROUND: The deubiquitinase USP7 has been identified as an oncogene with key roles in tumorigenesis and therapeutic resistance for a series of cancer types. Recently small molecular inhibitors have been developed to target USP7. However, the anticancer mechanism of USP7 inhibitors is still elusiv...
Autores principales: | Peng, Yuchong, Liu, Youhong, Gao, Yingxue, Yuan, Bowen, Qi, Xuli, Fu, Yuxin, Zhu, Qianling, Cao, Tuoyu, Zhang, Songwei, Yin, Linglong, Li, Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858727/ https://www.ncbi.nlm.nih.gov/pubmed/31730000 http://dx.doi.org/10.1186/s13046-019-1457-8 |
Ejemplares similares
-
PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability
por: Peng, Yuchong, et al.
Publicado: (2023) -
Usp16 regulates kinetochore localization of Plk1 to promote proper chromosome alignment in mitosis
por: Zhuo, Xiaolong, et al.
Publicado: (2015) -
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
por: Yuan, Bowen, et al.
Publicado: (2018) -
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
por: Yin, Linglong, et al.
Publicado: (2018) -
Correction to: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/. BRCA1 DNA damage repair complex in prostate cancer cells
por: Yin, Linglong, et al.
Publicado: (2022)